Johnson David Lee Insider Trades

Insider Trading History

Track insider trading activity for Johnson David Lee. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Vera Therapeutics
Vera Therapeutics VERA
Chief Operating Officer
Holding Value $1.43M 45,727 shares
Last Trade
Feb 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$108k 2,579 shares
$41.98
$31.27
Caribou Biosciences
Caribou Biosciences CRBU
Director
Holding Value $90k 45,000 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$81k 45,000 shares
$1.80
$2.00
Vera Therapeutics
Vera Therapeutics VERA
Chief Operating Officer
Holding Value $1.25M 40,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.71M 40,000 shares
$42.74
$31.27
Vera Therapeutics
Vera Therapeutics VERA
Chief Operating Officer
Holding Value $1.51M 48,306 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$855k 20,000 shares
$42.76
$31.27
Caribou Biosciences
Caribou Biosciences CRBU
Director
Holding Value $81k 40,500 shares
Last Trade
Feb 20, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$57.1k 40,500 shares
$1.41
$2.00
Vera Therapeutics
Vera Therapeutics VERA
Chief Operating Officer
Holding Value $1.68M 53,800 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.57M 53,800 shares
$29.18
$31.27
Vera Therapeutics
Vera Therapeutics VERA
Chief Operating Officer
Holding Value $5M 160,000 shares
Last Trade
Jul 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.81M 160,000 shares
$36.29
$31.27
Caribou Biosciences
Caribou Biosciences CRBU
Director
Holding Value $79k 39,500 shares
Last Trade
Feb 20, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$269k 39,500 shares
$6.81
$2.00
Caribou Biosciences
Caribou Biosciences CRBU
Director
Holding Value $43k 21,500 shares
Last Trade
Feb 21, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 21,500 shares
$6.12
$2.00
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Oct 05, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.96M 28,628 shares
$68.49
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $2.35M 34,384 shares
Last Trade
Sep 28, 2022 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.5M 22,000 shares
$68.11
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $946k 13,814 shares
Last Trade
Sep 01, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$188k 2,763 shares
$68.15
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $4.01M 58,487 shares
Last Trade
Sep 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$150k 2,208 shares
$68.15
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $3.67M 53,516 shares
Last Trade
Sep 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.9k 365 shares
$68.15
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $3.86M 56,384 shares
Last Trade
Sep 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$143k 2,103 shares
$68.15
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $3.85M 56,279 shares
Last Trade
Sep 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$188k 2,763 shares
$68.15
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $1.06M 15,460 shares
Last Trade
Sep 01, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$150k 2,208 shares
$68.15
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $3.8M 55,493 shares
Last Trade
Aug 01, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$219k 6,770 shares
$32.40
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $749k 10,935 shares
Last Trade
Aug 01, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$118k 3,645 shares
$32.40
$68.49
Global Blood Therapeutics
Global Blood Therapeutics GBT
Chief Commercial Officer
Holding Value $3.64M 53,151 shares
Last Trade
Aug 01, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$75.9k 2,342 shares
$32.40
$68.49

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up